Citation & Authors
BMC Med. 2025;23(1):26.
ABSTRACT · RESEARCH SUMMARY
Research summary
Each matched group contained 293,905 patients. Subsequent Sjögren’s disease risk was higher in the psoriasis group (HR 1.50; 95% CI 1.42–1.58), with stronger associations in patients with psoriatic arthritis and those using biologics. Transcriptomic analyses additionally identified shared pathways involving immune cell recruitment, cytokines, and interferon responses, supporting further research into common mechanisms.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
